You have these extremely popular GLP-1s that are driving a lot of interest in exploring this sort of injectable medication
The injectable evidence base in humans is, as of this writing, effectively empty
These findings suggested that the increased insulin release associated with C3G treatment, primarily results from C3G stimulating intestinal endocrine L cell STC-1 to secrete GLP-1 rather than directly affecting islet cell NIT-1 in a high glucose environment (Fig
P., Supriatna, I., Yudi, Y
doi: 10.3389/fnagi.2018.00180 11 BuawangpongN.PinyopornpanishK.Siri-AngkulN.ChattipakornN.ChattipakornS
Topical GHK-Cu products are common for skin and hair research, and some investigators explore the peptides role in promoting healthier looking hair through follicle-level regeneration